- mmunogenicity of TNF alpha inhibitors - focused on etanercept2015 | First Faculty of Medicine
- Case 1-2012: ANCA associated glomerulonephritis in combination with IgG4-positive mediastinal mass in a patient with ankylosing spondylitis treated with TNF alpha inhibitors2012 | Faculty of Medicine in Hradec Králové
- Adipokine profile is modulated in subcutaneous adipose tissue by TNF alpha inhibitors in patients with rheumatoid arthritis2011 | First Faculty of Medicine
- Efficacy and safety of certolizumab pegol in the treatment of rheumatoid arthritis2011 | First Faculty of Medicine
- Axial spondyloarthritis: Early diagnosis helps initiate effective treatment2018 | First Faculty of Medicine
- A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe2010 | Third Faculty of Medicine
- Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept2014 | Second Faculty of Medicine
- Multiple failures of TNF inhibitors in ankylosing spondylitis patient2019 | Faculty of Medicine in Hradec Králové
- Utilization of health care and costs for patients with rheumatoid arthritis treated with TNF-a inhibitors in the Czech Republic2009 | First Faculty of Medicine
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Are Anti-TNF-alpha Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature2016 | Second Faculty of Medicine
- Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis2016 | First Faculty of Medicine
- Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients2022 | First Faculty of Medicine, Second Faculty of Medicine